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Introduction
The ectoderm is established during mammalian gastrulation from
the anterior-distal portion of the pre-streak primitive ectoderm.
Although fated spatially, transplantation experiments demonstrate
that at this early stage, the cells are pluripotent and retain the
ability to contribute to tissues derived from other germ layers,
such as mesoderm (Beddington, 1982; Lawson et al., 1991). As
gastrulation proceeds, the ectodermal precursors move in a
proximal and posterior direction (Lawson et al., 1991), so that at
the completion of gastrulation they comprise the entire inner
layer of the embryo. At this stage, the cells have lost pluripotence,
and have a differentiation potential limited to the ectodermal
lineages (Carey et al., 1995). In lower vertebrates, the formation
of ectoderm proceeds via a bipotent intermediate, definitive
ectoderm, which differentiates to form the two major ectodermal
lineages: surface ectoderm and neurectoderm (Hemmati-
Brivanlou and Melton, 1997). The transient and dynamic
appearance of differentiation intermediates during mammalian
gastrulation, and the complex differentiation environment created
within the embryo, has precluded identification of definitive
ectoderm in mammals. Fate-mapping studies of the embryo,
however, have suggested the presence of a bipotent ectoderm
progenitor during gastrulation (Lawson and Pedersen, 1992;
Quinlan et al., 1995). The ability to form, recognize and
manipulate the differentiation of definitive ectoderm is crucial to
understanding the determination of cell fate in the ectoderm. The
ability to progress via a definitive ectoderm intermediate will
underpin the development of rational and efficient methodologies
for the derivation of specific ectodermal cell populations from
pluripotent cells in culture for use as experimental models or to
produce cells with therapeutic applications.
The establishment of ectoderm can be modelled in vitro by
directed differentiation of pluripotent embryonic stem (ES) cells in
response to signals within HepG2 cell-conditioned medium
(MEDII) (Rathjen et al., 2002; Rathjen et al., 1999). Aggregation
and differentiation of ES cells in MEDII as embryoid bodies in
MEDII (EBMs), results in the initial formation of a second
pluripotent cell population, early primitive ectoderm-like (EPL)
cells, followed by the emergence of a homogeneous population of
neurectoderm (Rathjen et al., 2002). Analysis of differentiation
potential and gene expression as differentiation proceeds in EBMs
suggests that establishment of neurectoderm recapitulates
embryonic development (Rathjen et al., 2002) and predicts
formation of a cell population equivalent to the definitive ectoderm.
Studies in lower vertebrates have determined that the secreted
molecule BMP4, a member of the bone morphogenic protein
family, is an important factor in the patterning of definitive
ectoderm and induces differentiation towards surface ectoderm
(Hemmati-Brivanlou and Melton, 1997; Wilson and Hemmati-
Brivanlou, 1995). In Xenopus laevis, BMP4 has been shown to
suppress neural tissue and induce surface ectoderm from the
definitive ectoderm (Wilson and Hemmati-Brivanlou, 1995). Later
studies demonstrated that the molecules chordin and noggin, which
are expressed in the dorsal blastopore lip and can induce neural
tissue from animal pole explants, bound to and inhibited BMP4
(Piccolo et al., 1996; Zimmerman et al., 1996). Thus, in X. laevis
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Summary
The formation and differentiation of multipotent precursors underlies the generation of cell diversity during mammalian development.
Recognition and analysis of these transient cell populations has been hampered by technical difficulties in accessing them in vivo. In
vitro model systems, based on the differentiation of embryonic stem (ES) cells, provide an alternative means of identifying and
characterizing these populations. Using a previously established mouse ES-cell-based system that recapitulates the development of the
ectoderm lineage we have identified a transient population that is consistent with definitive ectoderm. This previously unidentified
progenitor occurs as a temporally discrete population during ES cell differentiation, and differs from the preceding and succeeding
populations in gene expression and differentiation potential, with the unique ability to form surface ectoderm in response to BMP4
signalling.












embryos, the ectoderm is patterned by the secretion of BMP
antagonists from the dorsal blastopore lip, or Spemann’s organizer:
BMP signalling is active ventrally, and induces the formation of
surface ectoderm, whereas dorsal BMP signalling is inhibited, and
the cells adopt a neural fate (Hemmati-Brivanlou and Melton,
1997).
Gene-expression and gene-knockout studies have demonstrated
that BMP4 is required for normal early development and has a
multitude of functions (Hogan, 1996a; Hogan, 1996b; Zhao, 2003),
including an involvement in the establishment of mesoderm at
gastrulation (Winnier et al., 1995). More informatively, tissue-
specific knockout of the BMP4 receptor Bmpr1a from the epiblast
results in a reduction, but not complete loss, of surface ectoderm
formation, suggesting that BMP signalling is involved in the
patterning of this lineage during gastrulation (Davis et al., 2004).
Several approaches have been reported for the direction of ES
cells to cells of the neural ectoderm or surface ectoderm lineages
(Li et al., 1998; Rathjen et al., 2002; Rathjen and Rathjen, 2003;
Troy and Turksen, 2005), but scant attention has been paid to the
formation and characterization of the early progenitors of the
ectoderm lineage within these protocols. Here, differentiation of
ES cells to ectoderm in response to MEDII was used to identify
and characterize transient cell populations that arise during
establishment of the lineage. Three temporally distinct cell
populations, defined by gene expression, differentiation potential
and response to BMP4, were identified during ES cell
differentiation in EBMs; the primitive ectoderm, definitive
ectoderm and neurectoderm. The existence of a definitive ectoderm
progenitor in mammals has not been demonstrated in vivo or
during differentiation of pluripotent cells in vitro, although the
existence of this intermediate has been previously implied (Rathjen
et al., 2002). Here, the definitive ectoderm has been identified in
EBMs as a population of cells that is present between the loss of
pluripotence and upregulation of the neural markers; they comprise
a transient population with the unique differentiation potential to
form surface and neural ectoderm, but not mesoderm and endoderm.
Results
Gene expression demarcates four temporally distinct cell
populations formed during differentiation of EBM
Differentiation of ES cells as aggregates in the presence of MEDII
(embryoid bodies in MEDII; EBMs) results in directed
differentiation to neurectoderm (Rathjen et al., 2002).
Differentiation can be followed morphologically, with the initial
formation of smooth and amorphous aggregates that develop a
central cavity approximately 4 days after aggregation. This is
followed by the elaboration of epithelial layers, which become
progressively more stratified with time. Previous analysis has
shown that expression of the primitive ectoderm marker Fgf5
(Haub and Goldfarb, 1991; Pelton et al., 2002; Rathjen et al.,
1999) increases between day 2 and day 5. Levels of the pluripotent
marker Oct4 drop between day 4 and day 6, and a near-homogenous
population of neural progenitors form by day 9 (Rathjen et al.,
2002). Northern blot and RT-PCR analysis of a number of genetic
markers was used to map more precisely the temporal limits of the
pluripotent primitive ectoderm-like and the neurectoderm
populations and to reveal any additional intermediate populations
that arise as differentiation proceeds in EBMs.
Sox2, which is a marker of the pluripotent lineage (Wood and
Episkopou, 1999), was expressed in ES cells, then was reduced by
about 15% in EBMs at day 1 (EBM1) and maintained at
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approximately 50% ES cell expression level until day 9 (EBM9)
(Fig. 1A). Oct4 expression closely followed the pattern of Sox2 to
EBM5, after which expression steadily decreased (Fig. 1A). Rex1,
Spp1 and Nanog, which are all markers of the inner cell mass
Fig. 1. Analysis of differentially expressed genes during differentiation
within EBMs. RNA was isolated from ES cells and EBM1-EBM9 and
analysed for the expression of the pluripotent cell marker Sox2 and Oct4 (A),
the ICM markers Opn, Nanog and Rex1 (B), the primitive ectoderm markers
Lefty2 (C) and Fgf5 (D), the extracellular matrix proteins laminin and Col4a4
(collagen IV) (E), prospective definitive ectoderm markers Penk1 and Pard6b,
the neural marker Lmx1a (F) and the neural marker Pax6 (G). Expression
levels were determined by either northern blot analysis (Col4a4, Fgf5,
laminin, Nanog, Opn, Pax6, Penk1, Rex1, Sox2), RT-PCR (Lmx1a, Pard6b) or
real-time PCR (Lefty2). The expression of GAPDH or actin was used as a
loading control. Gene expression has been determined on at least two












(ICM) (Botquin et al., 1998; Chambers et al., 2003; Mitsui et al.,
2003; Rogers et al., 1991), were expressed in ES cells but
downregulated by EBM2 (Fig. 1B). Nanog is re-expressed in the
posterior primitive ectoderm during embryogenesis (Hart et al.,
2004) but no re-expression of Nanog was seen in EBMs. As
expected, expression of Fgf5 was detected between EBM2 and
EBM5 (Fig. 1D); this population was also marked by increased
expression of Lefty2 between day 1 and day 4 (Fig. 1C).
Expression of the extracellular matrix proteins laminin and
collagen IV was upregulated in EBM6 and later (Fig. 1E). The
upregulation of these markers is coincident with the downregulation
of Fgf5 and Lefty2 and loss of primitive ectoderm-like cells. Our
previous reports (Rathjen et al., 2002) and the expression of neural
markers Pax6 and Lmx1a (Chizhikov and Millen, 2004) here (Fig.
1F,G), suggest that neurectoderm formation initiates between EBM7
and EBM8. This gene-expression profile implies that a transient
intermediate population is present after the loss of EPL cells,
between EBM5 and EBM6, and before the upregulation of
neurectoderm-specific markers in EBM7-EBM8. Microarray
comparison of ES cells, EBM3, EBM6 and EBM9, identified a
number of genes that were upregulated on EBM6 relative to both
EBM3 and EBM9, and thus are potential markers of this population.
Preproenkephalin1 (Penk1), a neuropeptide transmitter (Konig et
al., 1996), and Pard6b, a protein involved in establishing cell
polarity (Lin et al., 2000; Suzuki and Ohno, 2006), showed elevated
expression in EBM5-EBM7, and EBM6-EBM7 populations,
respectively (Fig. 1F). This is consistent with the presence of a
temporally discrete population.
Identification of a transient cell population consistent with
definitive ectoderm: formation of early epidermal
progenitors from EBM6 in response to BMP4
In X. laevis, neurectoderm and surface ectoderm are established
from a common bipotent progenitor, the definitive ectoderm, with
formation of surface ectoderm occurring in response to signalling
by BMP4 (Wilson and Hemmati-Brivanlou, 1995). Similarly, human
ES cells, which form primitive streak-like intermediates and
mesoderm in response to BMP4, form surface ectoderm in response
to BMP4 when the ability to differentiate to mesoderm is blocked
by addition of DAPT, an antagonist of -secretase (Hughes et al.,
2009). To identify a population capable of forming surface ectoderm,
and consistent with definitive ectoderm, during EBM development
we used an assay based on the differentiation response of cells to
exogenously added BMP4. EBM5.5 were seeded into individual 2
ml wells and cultured in 50% MEDII for 12 hours to an EBM6
equivalent. At this point, the medium was changed to chemically
defined medium supplemented with varying concentrations of
BMP4, between 0 and 30 ng/ml. After 2 days, a distinct
morphological difference was observed between EBMs cultured in
10 ng/ml BMP4 compared with untreated EBMs (Fig. 2A-D).
Outgrowths derived from untreated EBMs comprised a sheet of
tightly packed cells with a high nuclear-to-cytoplasmic ratio (Fig.
2B,D). Focal rosette formation could be identified, in keeping with
early neural differentiation (Fig. 2B,D, closed arrow). With
continued culture, neuron extensions were observed; these have
previously been shown to express NeuN and tubulin II (Rathjen
et al., 2002). By contrast, BMP4-treated EBMs were surrounded by
well-differentiated epithelial cells that were similar in appearance
to early epidermal progenitor cells (Troy and Turksen, 2005). These
cells were characterized by a low nuclear-to-cytoplasmic ratio and
well-defined intercellular junctions (Fig. 2A,C, open arrows).
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Individual EBMs were scored for the presence of the large, flat
cell type and neural extensions 2 days and 6 days after the addition
of BMP4, respectively (Fig. 2E). The morphologically distinct,
large, flat outgrowths were barely detected in untreated EBMs, but
were seen in 14% of EBMs cultured in 1.25 ng/ml BMP4, and up
to 80% of EBMs cultured in 10-30 ng/ml BMP4. The increase in
the formation of this cell type was accompanied by a decrease in
the presence of neural extensions, from 75% of EBMs cultured in
<1.25 ng/ml BMP4 to approximately 38% in EBMs cultured in 10-
30 ng/ml BMP4.
Early in embryogenesis, around 8 d.p.c., the putative epidermis
comprises a single layer of proliferating cells, the stratum
germinatum, which is overlain by the periderm (Turksen and Troy,
1998). Both cell populations express keratin8 and keratin18,
markers of simple epithelial cells (Turksen and Troy, 1998). In situ
hybridization was used to detect the expression of Krt18 in
outgrowths from BMP4-treated and untreated EBM. As expected,
Krt18 expression was detected strongly in the outgrowths from
BMP4-treated EBMs (Fig. 2Fi), but only poorly in the outgrowths
from untreated aggregates (Fig. 2Fii), which is consistent with the
formation of an early epidermal progenitor. As would be expected,
fewer cells were positive for Sox1 expression in outgrowths from
BMP4-treated aggregates when compared with untreated controls
(data not shown). Outgrowths from BMP4-treated aggregates were
analyzed for the expression of additional early epidermal markers
desmoplakin, E-cadherin and cytokeratin 8 (Troy and Turksen,
2005) by immunofluorescence. Cells within the large, flat
outgrowths were positive for these markers, strongly suggesting
the formation of an epidermal progenitor from EBM6 in response
to BMP4 (Fig. 2G-J). Consistent with this conclusion, addition of
BMP4 to EBM6.5 did not result in the upregulation of the primitive
streak marker brachyury (T) or the endoderm marker Sox17 (Fig.
2K).
Differential response to BMP4 defines four populations of
cells during EBM development
The time that definitive ectoderm was present within EBM was
defined by analysing the response of cells to BMP4 throughout
EBM development. EBMs between day 4 and day 5.5 cultured
with BMP4 differentiated to a population of cells that were
morphologically distinct from surface epithelium, and contained
areas of beating cardiomyocytes (Fig. 3Ai). The formation of
beating cardiomyocytes was not seen from EBM4 cultured without
BMP4 (Fig. 3Aii,iii). The ability of cells to give rise to mesoderm
in response to BMP4 was lost abruptly between EBM5.5 and
EBM6 (Fig. 3Ai), corresponding to the downregulation of Fgf5.
This suggested that mesoderm formation in response to BMP4 was
a characteristic of pluripotent EPL cells. This response also
distinguishes these cells from ES cells that are maintained in the
presence of BMP4 signalling (Ying et al., 2003). Outgrowths from
EBM4 cultured in 10 ng/ml BMP4 were analysed by in situ
hybridization for brachyury and compared with untreated EBM4.
Consistent with the formation of terminally differentiated
mesodermal derivatives late in differentiation in aggregates treated
with BMP4, brachyury-expressing cells were detected in these
bodies 2 days after BMP4 addition (data not shown). To test
whether the formation of mesoderm in response to BMP4 is a
general characteristic of EPL cells, EBM2-EBM4 were formed
from a cell line in which GFP had been knocked-in to one allele
of the brachyury locus (Fehling et al., 2003). These were analyzed
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and compared with untreated controls. GFP upregulation was
detected from BMP4-treated EBM2-EBM4, but not in the untreated
controls (Fig. 3B), correlating EPL cell gene expression and BMP4
induction of mesoderm.
The loss of EPL cells between days 5 and 6 correlated with the
ability of cells to differentiate to neural cells, and surface ectoderm
in the presence of BMP4 (Fig. 3Ci,ii), suggesting that before this
point, BMP4 effectively suppressed the formation of the ectodermal
lineages (Fig. 3Aiii). The presence of neural extensions in BMP4-
treated EBM5-EBM7 was reduced in comparison to EBM8 and
EBM9, potentially reflecting the ability of these cells to form
surface epithelium in response to BMP4. Surface epithelium
formation was low, but not absent, in EBM4.5 and EBM5, and
increased between EBM5 and EBM5.5. Surface epithelium
formation peaked from EBM5.5 to EBM6.5 and was then gradually
lost. Together, these results suggest that definitive ectoderm: (1)
was present at a low level from day 5, coincident with late EPL
cells; (2) comprised the major population after the loss of
pluripotence; and (3) was gradually more committed to the neural
lineage after day 7. The differential response to BMP4 suggests
that EPL cells persist as the majority population up to day 5 and
are lost by day 6.
BMP4 induces Smad phosphorylation during in vitro
ectoderm differentiation
BMP4 signals are most commonly transduced by a type 1 receptor,
primarily ALK3 or ALK6, in a complex with BMPRII and result
in the phosphorylation of Smad1, Smad5 or Smad8 (Shi and
Massague, 2003). To confirm that this pathway was active in our
system, EBM4 and EBM6 were exposed to BMP4 and assayed
after 15 and 30 minutes, for Smad protein phosphorylation, by
western blot using an antibody that specifically recognizes only
phosphorylated forms of Smad1, Smad5 or Smad8 (Fig. 4A).
Without addition of exogenous BMP4, the level of phosphorylated
Smad proteins was very low (EBM4), or not detected (EBM6).
Fig. 2. Addition of BMP4 to EBM6 results in the formation of surface
ectoderm. (A-D)EBM5.5 were seeded for 12 hours before changing to
chemically defined medium with (A,C) or without (B,D) 10 ng/ml BMP4.
Bodies were cultured for a further 2 days. Open arrows indicate the large, flat
cells that surround BMP4-treated EBMs. Closed arrows indicate the stellate-
like cell structures reminiscent of neural progenitors that form from untreated
aggregates. Photomicrographs were taken under phase contrast on day 2 at 4
(A,B) and 20 magnification (C,D). (E)EBM5.5 were seeded for 12 hours
before changing to chemically defined medium supplemented with 0, 0.31,
0.63, 1.25, 2.5, 5, 10, 20 and 30 ng/ml BMP4. Bodies were cultured for a
further 6 days and scored for the presence of surface epithelial outgrowths (on
day 2) or neuronal extensions (on day 6) by morphology. n3, approximately
24 bodies per treatment, error bars denote s.e. (F)EBM5.5 were seeded for 12
hours before changing to chemically defined medium with (i) or without (ii)
10 ng/ml BMP4. After culture for a further 2 days, the bodies were fixed in 4%
PFA and analyzed for the expression of the surface ectoderm marker Krt18 by
whole-mount in situ hybridization. Photomicrographs were taken under bright-
field (main pictures) or phase-contrast (insets) illumination. (G-J)EBM6 were
seeded onto gelatinized glass coverslips in chemically defined medium with 10
ng/ml BMP4. Cells were cultured for 2 days and analyzed for the expression
of desmoplakin (G; green), E-cadherin (H; red) and cytokeratin 8 (I; green) by
immunofluorescence. Cell nuclei stained with DAPI. (J)EBM6.5 and EBM6.5
that had been cultured in chemically defined medium with (+) or without (–)
BMP4 for 24, 48 and 72 hours were analyzed for the expression of the
primitive streak marker brachyury and the definitive endoderm marker Sox17
by RT-PCR. RNA isolated from embryoid bodies on day 4 and EPLEBs (Lake












The low level of phosphorylated Smad proteins detected in EBM4
in serum (Fig. 4A, time 0) might reflect the response of these cells
to the presence of a BMP within the serum. Smad protein
phosphorylation was readily detectable in both populations after
exposure to BMP4, confirming that BMP4 is signalling via Smad
protein phosphorylation.
Components of this signalling pathway were analyzed in ES
cells and EBM4-EBM8 to determine whether variation in
expression levels or protein usage occurred during differentiation.
Protein extracts from ES cells and EBM4-EBM8 were analyzed by
western blot for the presence of total Smad1, Smad5 and Smad8
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(Fig. 4B). The levels of Smad5 and Smad8 proteins were unchanged
in all the cell samples tested. Smad1 was expressed at lower levels
in ES cells compared with other cell populations tested.
Expression of the receptors was analyzed by qRT-PCR in ES
cells, EBM4, EBM6 and EBM9. Transcripts encoding ALK3 and
BMPRII (Fig. 4C), but not ALK6 (data not shown), were detected,
suggesting that an ALK3-BMPRII receptor complex was present
in all populations. Although the mRNA levels of ALK3 and
BMPRII increased with differentiation, such that EBM9 expressed
approximately threefold higher levels than ES cells, the ratio of
ALK3 to BMPRII mRNA in each cell population remained
approximately equivalent.
ES and EPL cells can be distinguished molecularly by
their response to BMP4
We compared the levels of phosphorylated Smad proteins after
BMP4 stimulation between ES cells and EPL cells. Without BMP4
addition, very little phosphorylated Smad protein was detected in
ES cells or EBM on the day of analysis (Fig. 5; data not shown).
In comparison, the addition of BMP4 resulted in an upregulation
of phosphorylated Smad levels in all samples. A comparison of
BMP4-treated ES cells with EBM2, EBM3 and EBM4, showed
that levels of phosphorylated SMAD were higher in the EBMs
(Fig. 5A,Bi); quantification of EBM4 and ES cell levels showed
that this difference was significant (Fig. 5Bii). Smad protein
phosphorylation was not consistently elevated in BMP4-treated
Fig. 3. Addition of BMP4 to differentiating EBMs distinguishes the
intermediate cell populations. (A)EBM3.5-EBM7.5 were seeded at 12
hourly intervals (i), or EBM3.5 were seeded (ii,iii) and cultured for 12 hours
before changing to chemically defined medium with or without 10 ng/ml
BMP4 (approximately 24 bodies per treatment). Bodies were cultured for 6
days and scored for the presence of beating cardiomyocytes (i, ii) and neural
extensions (iii). n3, error bars denote s.e. (B)EBMs formed from GFP-Bry
ES cells were seeded on day 1.5 (i, iv), day 2.5 (ii, v) and day 3.5 (iii, vi) of
differentiation and cultured for 12 hours before changing to chemically
defined medium with (i, ii, iii) or without (iv, v, vi) 10 ng/ml BMP4. Bodies
were cultured for a further 3 days before being analyzed for the expression of
GFP by fluorescent microscopy (green, indicated by arrowheads) or
autofluorescence (red). Fluorescence are overlaid onto photomicrographs
taken using phase-contrast illumination. (C)Approximately 24 EBM3.5-
EBM7.5 were seeded at 12 hourly intervals and cultured for 12 hours before
changing to chemically defined medium containing 10 ng/ml BMP4. Bodies
were cultured for 6 days and scored for the presence of surface epithelial
outgrowths (on day 2) and neural extensions (on day 6). n3, error bars
denote s.e.
Fig. 4. EBMs are capable of responding to BMP4 signalling. (A)EBM4
and EBM6 were placed into chemically defined medium with or without
BMP4 for 15 and 30 minutes. Protein extracts were analyzed by western blot
for the presence of phosphorylated Smad proteins. Actin was used to
normalize for protein loading. (B)Western blot analysis of protein isolated
from ES cells and EBM4-EBM8 for the presence of Smad1, Smad5 and
Smad8. Actin was used to normalize for protein loading. (C)Real-time RT-
PCR analysis of RNA isolated from ES cells, EBM4, EBM6 and EBM9 for the












EBM1; interestingly the level of Smad5 protein appeared
diminished on this day compared with ES cells and EBM2. The
ability to respond to BMP4 with Smad phosphorylation was
acquired between 24 and 48 hours after exposure of ES cells to
MEDII (Fig. 6Aii), and correlates with the loss of ICM markers.
This response provides an early functional readout of EPL cell
formation.
Discussion
During development, the presence and potential of the
differentiation intermediates that occur in the ontogeny of many
differentiated cell populations is poorly understood. The
differentiation of ES cells in culture to populations representative
of embryonic lineages has been postulated to recapitulate early
embryonic development, providing paradigms for the identification
and characterization of cell populations that arise transiently during
cell type formation (Choi et al., 1998; Kennedy et al., 1997;
Rathjen et al., 2002; Yamashita et al., 2000). Differentiation of ES
cells within EBMs appears to recapitulate the embryonic processes
that lead to the establishment of the ectodermal lineages on the
anterior side of the gastrulating embryo (Rathjen et al., 2002),
providing a model for the identification and characterization of
ectoderm intermediates. In previous work, we hypothesized that
formation of neurectoderm within EBMs proceeded via the
establishment of transient differentiation intermediates that are
equivalent to intermediate populations postulated to arise within
the embryo (Rathjen et al., 2002). In this report, we provide genetic
and functional evidence for the existence of these populations, and
demonstrate that one of these has properties that are consistent
with definitive ectoderm, a population of cells in mammals that
has proven refractory to characterization, both in vivo and in vitro.
Gene expression demarcates three temporally distinct cell
populations that arise during neurectoderm establishment
We have refined and extended our earlier description (Rathjen et
al., 2002) of pluripotent cell populations that precede establishment
of neurectoderm gene expression in the EBM system. The starting
population of ES cells was shown to be equivalent to the pluripotent
cells of the inner cell mass, expressing the pluripotent markers
Oct4 and Sox2, and the ICM markers Rex1, Opn and Nanog.
Differentiation of this population occurred within 24 hours of
aggregation and exposure to MEDII, as demonstrated by reduced
transcript levels of Rex1, Lefty1 and Opn. However, 48 hours was
required for the complete downregulation of ICM-specific genes,
acquisition of the differential response to BMP4, and transition to
a population of EPL cells expressing Fgf5, Oct4 and Sox2. Elevated
expression of Lefty2 was also correlated with the presence of EPL
cells within EBM.
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Loss of pluripotence, as defined by an alteration in differentiation
outcome between EBM5 and EBM6, with EBM5.5, but not EBM6,
capable of forming beating cardiomyocytes after BMP4 treatment,
coincided with downregulation of Fgf5 and upregulation of genes
encoding laminin and collagen IV. The EBM system therefore
comprises a population of EPL or primitive ectoderm cells between
days 2 and 5.5. Loss of pluripotence appeared to be sharp and rapid,
with alterations occurring to completion within 24 hours or 1-2 cell
cycles. This suggests a high degree of developmental synchrony
within the population. The trigger for the loss of pluripotence during
EBM development is not known, but is likely to be cell autonomous,
because no alterations to the culture conditions occur at this time.
A cell-autonomous trigger for primitive ectoderm differentiation
during gastrulation would enforce loss of pluripotence and prevent
inappropriate maintenance of potentially teratogenic cells within
the developing embryo. Within the embryo, active signalling that
arises from adjacent populations and signalling centres, such as the
extraembryonic endoderm and node, is likely to modulate the
differentiation outcome. Interestingly, loss of pluripotence was not
reflected in a rapid loss of Oct4 transcripts, suggesting that Oct4 is
not precisely correlated with pluripotence during gastrulation
(Mossman et al., 2005; Rathjen et al., 2002).
The expression of neurectoderm markers such as Pax6 and
Lmx1a did not immediately follow loss of pluripotence, but was
delayed for 1-2 days. EBMs at this stage expressed low levels of
markers that characterize pluripotent (Rex1, Opn, Nanog and Fgf5)
and neural (Pax6, Lmx1a and Sox1) (Rathjen et al., 2002) lineages,
and acquired the expression of novel genetic profile that included
Penk1 and Pard6b. A population of cells with this genetic signature
has not been previously identified during pluripotent cell
differentiation. This work defines a third intermediate cell
population that is formed temporally between the EPL or primitive
ectoderm cell and the establishment of neurogenesis, between day
5.5 and day 7 of the EBM system.
The definition of clear discrete intermediary populations during
the differentiation of ES cells within EBMs is described here using
gene expression and functional markers. A recent examination of
this differentiation system using changes in replication timing and
chromatin conformation also resulted in the definition of distinct cell
populations occurring during differentiation (Hiratani et al., 2009).
Moreover, both techniques – cell biology used by us, and epigenetics
used by Hiratani and colleagues – defined the same number of
distinct cell populations, and both outcomes aligned well.
Responsiveness to BMP4 provides evidence for functional
differences between differentiation intermediates
Changes in gene expression provide a temporal description of
successive progenitor populations in the EBM system, which can
Fig. 5. ES and EPL cells respond differently to BMP4.
(A)Western blot analysis of phosphorylated Smad proteins
in protein extracted from ES cells and EBM1-EBM3 (i),
and ES cells and EBM4 (ii) that had been exposed to 10
ng/ml BMP4 for 30 minutes, as denoted. SMAD5 and -
tubulin were used to normalize for protein loading. Western
blot was probed with Smad1, but protein levels were below
detection (data not shown). (B)The levels of
phosphorylated Smad proteins were determined and
expressed relative to -tubulin for ES cells and EBM4 cells
after exposure to 10 ng/ml BMP4 for 30 minutes. n3, error












in some cases be correlated with cell types formed during
embryonic development. The function of progenitor populations
can be assessed by evaluation of their potency and the repertoire
of cell lineages that can be formed during differentiation. Evidence
for functional relevance of the changes in gene expression seen
here was established by evaluating the variation in differentiation
outcome from these progenitor populations following exposure of
cells to BMP4.
Consistent with the observations of others (Winnier et al., 1995;
Ying et al., 2003), the ES and EPL cell states, at day 0 and day 2-
5.5 of differentiation, respectively, were distinguished by induction
of mesoderm in response to BMP4 in the latter, but not the former.
Formation of mesoderm was manifest in the upregulation of
brachyury expression and in further differentiation to cell types of
representative of mesoderm. Neural cell fates were almost
completely suppressed from late EPL cells (EBM4-EBM5.5)
cultured in the presence of BMP4.
Treatment of the differentiation intermediate present on day 6
with BMP4 induced a different response. Mesoderm was not
induced, the formation of neural lineages was suppressed, and a
novel cell population, which is not normally observed at significant
levels in either the EBM or embryoid body system, was induced.
Morphology and gene expression within this population were
indicative of the formation of surface ectoderm. This work is
consistent with similar observations in human ES cells. Human ES
cells are induced to form primitive streak-like intermediates and
mesoderm in response to BMP4. When the ability to form
mesoderm is blocked by addition of an agonist of -secretase, the
presence of BMP4 induces the formation of surface ectoderm
(Hughes et al., 2009).
Genetic signatures of differentiation intermediates in the EBM
system therefore reflect the formation of progenitor populations
with alternative functional properties. BMP4 induced non-neural
cell fates from pluripotent and committed populations with
alternative developmental choices.
Identification of a transient cell population with properties
consistent with the formation of definitive ectoderm
Mammalian definitive ectoderm has been proposed to exist by
analogy with X. laevis (Wilson and Hemmati-Brivanlou, 1995);
however, the potential transient and dynamic nature of an equivalent
population in the mammalian embryo and in EBs, coupled with a
lack of markers, has precluded identification and formal
characterization of this cell. Fate-mapping studies of the embryo
have suggested that surface and neural ectoderm arise from adjacent
zones of the anterior primitive ectoderm (Lawson and Pedersen,
1992), and marking of single or small groups of cells has
demonstrated the presence of cells within the proximal anterior of
the early streak embryo with the potential to contribute to both the
surface and neural ectoderm lineages, consistent with the presence
of a bipotent progenitor (Lawson and Pedersen, 1992; Quinlan et
al., 1995).
A differentiation intermediate present in EBM6 is temporally
consistent with definitive ectoderm, arising between primitive
ectoderm expressing Oct4 and Fgf5 and neural progenitors
expressing Pax6, Lmx1a and Sox1. This cell population expresses
a unique set of markers that is not associated with pluripotence or
neuroectoderm, and has a differentiation potential that includes
both neurectoderm and surface ectoderm. The cells within this
population do not form significant levels of mesoderm, endoderm
or extraembryonic lineage under any of the conditions that we
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have assessed. Downregulation of neural differentiation and
upregulation of a surface ectoderm equivalent in response to BMP4
is a differentiation profile shared by definitive ectoderm in
vertebrate embryos. BMP suppression of neural differentiation in
vivo (Wilson and Hemmati-Brivanlou, 1995; Wilson and Edlund,
2001) and during ES cell differentiation (Tropepe et al., 2001;
Ying et al., 2003) has been well documented, whereas definitive
ectoderm in X. laevis has been shown by genetic approaches to
form surface ectoderm in response to BMP4 (Wilson and Hemmati-
Brivanlou, 1995). Although EBM6 cells align with definitive
ectoderm in terms of ontogeny, genetic signature and differentiation
potential, the persistence of cells capable of forming neural
projections in BMP4-treated aggregates beyond day 5 does not
allow us to preclude the formation of a second, dedicated neural
progenitor during differentiation within EBMs.
BMP4 signalling activates Smad phosphorylation in
differentiation intermediates
Differences in the response of distinct, closely related differentiation
intermediates to BMP4 prompted an investigation of the molecular
basis for this pleiotropy. BMP receptors and Smad proteins were
present at all stages of differentiation, with no obvious differences
in levels that could explain diverse responses to the ligand.
Treatment with BMP4 was shown to result in phosphorylation of
Smad proteins in each of the differentiation intermediates tested.
The most striking difference between the populations in terms of
the molecular response to BMP4 was in the levels of
phosphorylated Smad proteins, which were significantly higher in
BMP-treated EPL cells than in BMP-treated ES cells, providing a
molecular marker for EPL cells in culture.
Although these data suggest that BMP4 signalling in
differentiation intermediates of the ectoderm includes Smad
phosphorylation, the differential response of alternative progenitor
populations points to a greater complexity. This might be manifest
in differential activation of alternative signalling pathways that are
characteristic of each cell type in response to BMP4 or other
molecules within the differentiation milieu, or the induction of
distinct subsets of genes in response to a common Smad-based
pathway.
Conclusions
The ability to control differentiation in culture will rely on the
ability to form and precisely differentiate intermediate progenitor
states. Characterization of the differentiation intermediates that
occur as ES cells differentiate to the ectoderm lineage provides a
description of the presence and persistence of the differentiation
intermediates. This includes the formation and subsequent
differentiation of a population consistent with an immediate post-
pluripotent definitive ectoderm progenitor, which arises as
pluripotent cells differentiate to an early neural progenitor. We
hypothesize that these intermediates will underpin the development
of rational differentiation protocols and supply material for the
analysis of the differentiation machinery, providing a system for
the analysis of the genetic and epigenetic control of lineage
establishment from pluripotent cells.
Materials and Methods
Cell culture
The D3 ES cell line (Doetschman et al., 1985) and GFP-Bry ES cells (Fehling et al.,
2003) were used. The routine culture of ES and EPL cells, formation of cellular
aggregates (EBMs) and the production of MEDII were as described previously
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cells within EBMs was analysed by seeding aggregates onto gelatin-treated tissue
culture grade plasticware (Falcon) for approximately 12 hours in 50% MEDII
(Rathjen and Rathjen, 2003) before the medium was replaced with chemically
defined medium (Rathjen and Rathjen, 2003) with or without BMP4, as noted in the
text. Outgrowths were examined microscopically 2, 4 and 6 days after seeding and
scored for the presence of neural projections, flattened epithelial sheets and beating
cardiomyocytes. Cells with neural projections have been shown previously to express
tubulin-III and NeuN (Rathjen et al., 2002). Generally, for each experimental
condition, 24 individual wells were seeded with randomly selected cellular aggregates
and experiments were repeated three times. At all differentiation points tested, the
morphology of the cellular aggregates was highly consistent and in accordance with
that described previously (Rathjen et al., 2002). Alkaline phosphatase activity was
detected using the alkaline phosphatase activity detection kit (Sigma) modified as
described (Rathjen et al., 1999).
Northern blot analysis
Total cytoplasmic RNA was isolated using RNAzolTM (TelTest). Northern blot
analysis was performed essentially as described in Breeden Lab Methods
(http://www.fhcrc.org/labs/breeden/Methods/Northern_blot). Filters were rinsed in
2SSC, crosslinked with 120 mJ at 254 nm in a UV Stratalinker 1800 (Stratagene),
washed in 1SSC, 0.1% SDS at 65°C for 30 minutes before prehybridization and
hybridization in Church hybridization buffer (Church and Gilbert, 1984). Filters
were washed for 220 minutes in 1SSC, 0.1% SDS, exposed to an imaging plate
(Fujifilm) and signal detected on a Bio-Rad FX imager (Bio-Rad). Band quantification
was performed using Bio-Rad Quantity One software. Radioactive DNA probes
were synthesized using the DECAprimeTM II Randomly Primed DNA Labeling Kit
(Ambion). DNA fragments used for analysis of Fgf5, Rex1 and GAPDH were as
described previously (Lake et al., 2000; Rathjen et al., 1999). cDNA fragments to be
used as probes for mRNA encoding of Opn, laminin, collagen IV, Sox2 and Penk1
were cloned into pGEM®-T Easy (Promega) and released by digestion with EcoRI.
Bands were detected with a Fuji Imaging Plate, which was scanned with a Molecular
Imager FXTM (Bio-Rad) and analyzed with Quantity OneTM software (Bio-Rad).
Semi Quantitative RT-PCR
cDNA was synthesized from total RNA with the Omniscript® RT kit (Qiagen). PCR
reactions contained 10 l Platinum® PCR Supermix (Invitrogen), 200 nM of each
primer and 50-100 ng of cDNA. Products were separated on a 2% (w/v) agarose gel,
and stained with SYBR® Gold (Invitrogen). Product bands were scanned with a
Molecular Imager FX (Bio-Rad) or captured on a BioDoc-It Imaging system. The
sequences, length of amplified products, annealing temperatures and cycle numbers
were: Pard6b (447 bp, 60°C, 24 cycles): 5-ACTACCACAAGGCGGTTTCC-3 and
5-TCCCGGACACTTCTATACCG-3; Actin (501 bp, 60°C, 26 cycles): 5-ATGGAT-
GACGATATCGCTG-3and 5-ATGAGGTAGTCTGTCAGGT-3; Lmx1a (500 bp,
60°C, 28 cycles): 5-ACTCAGGCAAAAGCGATGAT-3 and 5-ACCATAGGGGT-
GCATGTGAT-3;Brachyury (143 bp, 60°C, 28 cycles): 5-TGCTGCCTGTGAGT-




RNA and cDNA was prepared as previously described. The PCR reaction mix
comprised 12 l SYBR® Green PCR reaction mix (Invitrogen), 1 l ROX reference
mix (Invitrogen), 50 ng cDNA and 200 nM of each primer made up to a total volume
of 25 l with water. Samples were heated to 50°C for 2 minutes, then 95°C for 10
minutes, before being cycled 40 times through the following sequence on a 9600
thermocycler (ABI Prism): 95°C for 15 seconds, 56°C for 1 minute. The raw data
was analyzed using the Q-Gene software package (Muller et al., 2002; Simon,
2003). Primers were designed using Primer Express® software (Applied Biosystems).
The sequences and length of amplified products were: ALK3 (120 bp): 5-TTT CA -
ATGCAAGGATTCACCG-3and 5-AAAGAACGGACCTATAACAACAGGG-3;
ALK6 (79 bp): 5-GGCGGGTTAACTTCGGC-3 and 5-TTGCTCCTTTAA CTT -
TTTGTTTGC-3;BmpRII (96 bp): 5-AGAATGTTGACAGGAGACCGG-3and
5-CTTCAGGTTATCCAGGTCAAGGG-3;Lefty2 (360 bp): 5-TGTATTCTCA -
GTGAGCTT-3and 5-GCAGTCCCTGACATGGTA-3; Actin (89 bp): 5-CTG -
CCTGACGGCCAGG-3and 5-GATTCCATACCCAAGAAGGAAGG-3.
In situ hybridization analysis
Whole-mount in situ hybridization analysis of cellular aggregates was performed
using the method of Rosen and Beddington (Rosen and Beddington, 1993) with
modifications (Lake et al., 2000; Rathjen et al., 1999). Antisense and sense probes
were synthesized using a DIG RNA Labeling Kit (Roche). Plasmid details for Sox1
and brachyury were as described previously (Lake et al., 2000; Rathjen et al., 2002).
An 1165 bp HindIII fragment of Krt18 cDNA was a kind gift from Robert Oshima
(Singer et al., 1986). This fragment was cloned into the HindIII site of pBluescript®
KS. Antisense probes were generated by restriction with BamHI and transcription
with T3 RNA polymerase, sense probes were generated by restriction with XhoI and
transcription with T7 RNA polymerase.
Cellular protein extraction
Adherent cells were collected by incubating with 0.5-1.0 ml TEN buffer (40 mM
Tris-HCl, pH 7.4, 10 mM EDTA, 150 mM NaCl) for 5-10 minutes at 4°C. Cells in
suspension culture were simply collected by centrifugation and washed with PBS. A
volume of ice-cold lysis buffer [50 mM Tris-HCl, pH 7.0, 150 mM NaCl, 1% (v/v)
NP-40, 1 mM EDTA, 1 mM NaVO4, 50 mM NaF, 1 tablet of Complete Mini EDTA-
free protease inhibitor cocktail tablet (Roche) per 10 ml buffer, added immediately
before use] approximately equal to the volume of the cell pellet was added, and
incubated for 30-60 minutes at 4°C on a rotating platform. Cellular debris was
removed by centrifugation for 10 minutes, also at 4°C. Total protein concentration
was determined using the Bio-Rad protein assay procedure
SDS-PAGE and western blot analysis
SDS-PAGE and western blotting were carried out as previously described (Kavanagh
et al., 2005), with the following modifications. When AP-conjugated secondary
antibodies were being used Tris-buffered saline with 0.1% (v/v) Tween-20 (TBST)
was used in the place of phosphate-buffered saline. When the anti-phosphorylated
Smad antibody was being used as the primary antibody, blocking was performed
with 5% (w/v) bovine serum albumin (BSA, Sigma) in TBST as per the
manufacturer’s instructions. When AP-conjugated secondary antibodies were used,
membranes were developed by incubation with ECFTM substrate (Amersham
Pharmacia Biotech) reagents in the dark for 5 minutes, before being scanned with a
Molecular Imager FXTM (Bio-Rad) and analyzed with Quantity OneTM software
(Bio-Rad). Statistical analysis was performed using Microsoft Excel software.
Immunofluorescence
EBMs were grown in suspension culture for 6 days before being seeded onto gelatin-
treated glass coverslips in chemically defined medium with or without 10 ng/ml
BMP4. Medium was refreshed daily. After 48 hours, coverslips were fixed in ice
cold acetone for 5 minutes and stored in 1 PBS at 4°C. Fixed cells were blocked
with 1% BSA. Primary antibodies were sourced from AbCam and applied at 1:200.
We thank Rebecca Keough and Christopher Wilkinson for their help
with the microarray analysis of definitive ectoderm, Kenneth Lang for
assistance with gene expression analysis and Gordon Keller (Ontario
Cancer Institute, Toronto, Canada) for provision of the Bry-GFP ES
cell line. This work was supported by a grant from ARC SRC for the
Molecular Genetics of Development and donations from Raymond
Ryce.
References
Beddington, R. S. (1982). An autoradiographic analysis of tissue potency in different
regions of the embryonic ectoderm during gastrulation in the mouse. J. Embryol. Exp.
Morphol. 69, 265-285.
Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, C., Gross, M. K., Vriend, G. and
Scholer, H. R. (1998). New POU dimer configuration mediates antagonistic control of
an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev. 12, 2073-
2090.
Carey, F. J., Linney, E. A. and Pedersen, R. A. (1995). Allocation of epiblast cells to
germ layer derivatives during mouse gastrulation as studied with a retroviral vector.
Dev. Genet. 17, 29-37.
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and Smith,
A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in
embryonic stem cells. Cell 113, 643-655.
Chizhikov, V. V. and Millen, K. J. (2004). Control of roof plate formation by Lmx1a in
the developing spinal cord. Development 131, 2693-2705.
Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C. and Keller, G. (1998). A
common precursor for hematopoietic and endothelial cells. Development 125, 725-732.
Church, G. M. and Gilbert, W. (1984). Genomic sequencing. Proc. Natl. Acad. Sci. USA
81, 1991-1995.
Davis, S., Miura, S., Hill, C., Mishina, Y. and Klingensmith, J. (2004). BMP receptor
IA is required in the mammalian embryo for endodermal morphogenesis and ectodermal
patterning. Dev. Biol. 270, 47-63.
Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. and Kemler, R. (1985). The
in vitro development of blastocyst-derived embryonic stem cell lines: formation of
visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27-45.
Fehling, H. J., Lacaud, G., Kubo, A., Kennedy, M., Robertson, S., Keller, G. and
Kouskoff, V. (2003). Tracking mesoderm induction and its specification to the
hemangioblast during embryonic stem cell differentiation. Development 130, 4217-
4227.
Hart, A. H., Hartley, L., Ibrahim, M. and Robb, L. (2004). Identification, cloning and
expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Dev. Dyn. 230, 187-198.
Haub, O. and Goldfarb, M. (1991). Expression of the fibroblast growth factor-5 gene in
the mouse embryo. Development 112, 397-406.
Hemmati-Brivanlou, A. and Melton, D. (1997). Vertebrate embryonic cells will become
nerve cells unless told otherwise. Cell 88, 13-17.
Hiratani, I., Ryba, T., Itoh, M., Rathjen, J., Kulik, M., Papp, B., Fussner, E., Bazett-












1804 Journal of Cell Science 123 (10)
timing revealed by in vitro models of mouse embryogenesis. Genome Res. 20, 155-
169.
Hogan, B. L. (1996a). Bone morphogenetic proteins in development. Curr. Opin. Genet.
Dev. 6, 432-438.
Hogan, B. L. (1996b). Bone morphogenetic proteins: multifunctional regulators of
vertebrate development. Genes Dev. 10, 1580-1594.
Hughes, J. N., Dodge, N., Rathjen, P. D. and Rathjen, J. (2009). A novel role for
gamma-secretase in the formation of primitive streak-like intermediates from ES cells
in culture. Stem Cells 27, 2941-2951.
Kavanagh, S. J., Schulz, T. C., Davey, P., Claudianos, C., Russell, C. and Rathjen, P.
D. (2005). A family of RS domain proteins with novel subcellular localization and
trafficking. Nucleic Acids Res. 33, 1309-1322.
Kennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N. and Keller, G.
(1997). A common precursor for primitive erythropoiesis and definitive haematopoiesis.
Nature 386, 488-493.
Konig, M., Zimmer, A. M., Steiner, H., Holmes, P. V., Crawley, J. N., Brownstein, M.
J. and Zimmer, A. (1996). Pain responses, anxiety and aggression in mice deficient in
pre-proenkephalin. Nature 383, 535-538.
Lake, J., Rathjen, J., Remiszewski, J. and Rathjen, P. D. (2000). Reversible
programming of pluripotent cell differentiation. J. Cell Sci. 113, 555-566.
Lawson, K. A. and Pedersen, R. A. (1992). Clonal analysis of cell fate during gastrulation
and early neurulation in the mouse. Ciba Found. Symp. 165, 3-21.
Lawson, K. A., Meneses, J. J. and Pedersen, R. A. (1991). Clonal analysis of epiblast
fate during germ layer formation in the mouse embryo. Development 113, 891-911.
Li, M., Pevny, L., Lovell-Badge, R. and Smith, A. (1998). Generation of purified neural
precursors from embryonic stem cells by lineage selection. Curr. Biol. 8, 971-974.
Lin, D., Edwards, A. S., Fawcett, J. P., Mbamalu, G., Scott, J. D. and Pawson, T.
(2000). A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC
signalling and cell polarity. Nat. Cell. Biol. 2, 540-547.
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K.,
Maruyama, M., Maeda, M. and Yamanaka, S. (2003). The homeoprotein Nanog is
required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-
642.
Mossman, A. K., Sourris, K., Ng, E., Stanley, E. G. and Elefanty, A. G. (2005). Mixl1
and oct4 proteins are transiently co-expressed in differentiating mouse and human
embryonic stem cells. Stem. Cells Dev. 14, 656-663.
Muller, P. Y., Janovjak, H., Miserez, A. R. and Dobbie, Z. (2002). Processing of gene
expression data generated by quantitative real-time RT-PCR. Biotechniques 32, 1372-
1374, 1376, 1378-1379.
Pelton, T. A., Sharma, S., Schulz, T. C., Rathjen, J. and Rathjen, P. D. (2002).
Transient pluripotent cell populations during primitive ectoderm formation: correlation
of in vivo and in vitro pluripotent cell development. J. Cell Sci. 115, 329-339.
Piccolo, S., Sasai, Y., Lu, B. and De Robertis, E. M. (1996). Dorsoventral patterning in
Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86,
589-598.
Quinlan, G. A., Williams, E. A., Tan, S. S. and Tam, P. P. (1995). Neuroectodermal fate
of epiblast cells in the distal region of the mouse egg cylinder: implication for body plan
organization during early embryogenesis. Development 121, 87-98.
Rathjen, J. and Rathjen, P. D. (2003). Lineage specific differentiation of mouse ES cells:
formation and differentiation of early primitive ectoderm-like (EPL) cells. Methods
Enzymol. 365, 3-25.
Rathjen, J., Lake, J. A., Bettess, M. D., Washington, J. M., Chapman, G. and
Rathjen, P. D. (1999). Formation of a primitive ectoderm like cell population, EPL
cells, from ES cells in response to biologically derived factors. J. Cell Sci. 112, 601-
612.
Rathjen, J., Haines, B. P., Hudson, K. M., Nesci, A., Dunn, S. and Rathjen, P. D.
(2002). Directed differentiation of pluripotent cells to neural lineages: homogeneous
formation and differentiation of a neurectoderm population. Development 129, 2649-
2661.
Rogers, M. B., Hosler, B. A. and Gudas, L. J. (1991). Specific expression of a retinoic
acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and
spermatocytes. Development 113, 815-824.
Rosen, B. and Beddington, R. S. (1993). Whole-mount in situ hybridization in the mouse
embryo: gene expression in three dimensions. Trends Genet. 9, 162-167.
Shi, Y. and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane
to the nucleus. Cell 113, 685-700.
Simon, P. (2003). Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics
19, 1439-1440.
Singer, P. A., Trevor, K. and Oshima, R. G. (1986). Molecular cloning and characterization
of the Endo B cytokeratin expressed in preimplantation mouse embryos. J. Biol. Chem.
261, 538-547.
Suzuki, A. and Ohno, S. (2006). The PAR-aPKC system: lessons in polarity. J. Cell Sci.
119, 979-987.
Tropepe, V., Hitoshi, S., Sirard, C., Mak, T. W., Rossant, J. and van der Kooy, D.
(2001). Direct neural fate specification from embryonic stem cells: a primitive
mammalian neural stem cell stage acquired through a default mechanism. Neuron 30,
65-78.
Troy, T. C. and Turksen, K. (2005). Commitment of embryonic stem cells to an epidermal
cell fate and differentiation in vitro. Dev. Dyn. 232, 293-300.
Turksen, K. and Troy, T. C. (1998). Epidermal cell lineage. Biochem. Cell Biol. 76, 889-
898.
Wilson, P. A. and Hemmati-Brivanlou, A. (1995). Induction of epidermis and inhibition
of neural fate by Bmp-4. Nature 376, 331-333.
Wilson, S. I. and Edlund, T. (2001). Neural induction: toward a unifying mechanism.
Nat. Neurosci. 4, 1161-1168.
Winnier, G., Blessing, M., Labosky, P. A. and Hogan, B. L. (1995). Bone morphogenetic
protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev.
9, 2105-2116.
Wood, H. B. and Episkopou, V. (1999). Comparative expression of the mouse Sox1,
Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech. Dev. 86, 197-
201.
Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T., Naito,
M. and Nakao, K. (2000). Flk1-positive cells derived from embryonic stem cells serve
as vascular progenitors. Nature 408, 92-96.
Ying, Q. L., Nichols, J., Chambers, I. and Smith, A. (2003). BMP induction of Id
proteins suppresses differentiation and sustains embryonic stem cell self-renewal in
collaboration with STAT3. Cell 115, 281-292.
Zhao, G. Q. (2003). Consequences of knocking out BMP signaling in the mouse. Genesis
35, 43-56.
Zimmerman, L. B., De Jesus-Escobar, J. M. and Harland, R. M. (1996). The Spemann
organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86,
599-606.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
